close icon

S&P Global Can Disappoint in Next Couple of Years

In July last year we wrote an Elliott Wave analysis highlighting the possibility of a notable 40%+ correction in Moody’s stock. Seven months later now, the share price is little changed and the negative outlook remains valid. Today, we are going to examine Moody’s major rival – S&P Global Inc.

S&P Global is a ratings agency, benchmarks and data provider with an incredibly sound business model and a $78B market cap. The company is in the process of acquiring IHS Markit for roughly $44B, but that is another matter. What worries us is that SPGI’s weekly chart shows a pattern very similar to the one we found in Moody’s last year. Take a look.

S&P Global Stock facing a 40% Elliott Wave correction

Starting from the mid-1990s, S&P Global seems to have drawn a complete five-wave impulse. The pattern is labeled I-II-III-IV-V, where wave II occurred during the 2008 Financial Crisis. Wave III was a real delight to anyone smart or lucky enough to ride most of it. Its five sub-waves are also visible and marked 1-2-3-4-5.

Moody’s and S&P Global to Fall in Tandem

The coronavirus selloff in March 2020 put wave IV into place and sat the stage for a new high in wave V. The fact that wave IV ended shortly after touching the 38.2% Fibonacci level supports the idea that the following surge is a fifth wave.

According to the theory, a three-wave correction follows every impulse. If the count above is correct, we can expect a major decline in S&P Global stock to erase the entire wave V. A drop to the support area of wave IV near $200 – $170 makes sense. It would be an excellent opportunity to invest in this growing, profitable, wide-moat business.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Three Months Ahead of NovoCure ‘s 35% Plunge

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that the tumor treatment company was not only significantly overvalued, but in immediate danger of a large stock price drop. The stock had just fell 15% in one day, despite positive TTFields…

Read More »

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

Match ‘s SP500 Inclusion a Good Excuse to Reach $200

Match Group Inc. rose over 10% in post-market trading Friday following reports that it is going to be included in the S&P 500. The company, which owns Tinder, OkCupid and most other major dating apps in the U.S., has a market cap of over $41B. Despite the anticipated “summer of love”, though, this is not…

Read More »

Cameco Stock Seems to Have Finally Turned a Corner

Uranium spot prices are on the verge of breaking above $34/lb, up over 80% from the bottom of $18/lb reached in late-2016. Cameco, as one of the world’s top uranium producers, is now seeing its stock price rising in tandem. Yesterday, it closed at $19.16 after reaching $21.95 in June. We first covered Cameco in…

Read More »

A Fresh Look At Cigna ‘s Elliott Wave Super Cycle

In a case study article on Cigna, published in October, 2016, we examined how a fundamentally sound and undervalued stock can still drop nearly 90%. The reason for that crash didn’t lie in some company specific issue. Rather it happened to occur during the biggest financial crisis in 80 years. Nevertheless, we made the point…

Read More »

CBOE Takeover Rumor Lifts Stock to Elliott Wave Target

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and was hovering at new all-time highs. CBOE, in contrast, was still down 30% from its 2018 record, trading below $97 a share. For some reason, the market was ignoring the company’s…

Read More »

More analyses